Klafotaxim 500 mg.1000mg INJECTION
PDF Leaflet Revision Date: 11 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for various infections including genito-urinary, skin, respiratory, gastrointestinal, and meningitis.
Dosage (summary)
Adults: 2 g/day in divided doses; severe cases: 3-4 g/day. Pediatrics: 50-100 mg/kg/day.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Safety in pregnancy not established; low concentrations in breast milk.
Key Drug Interactions
- Nephrotoxic drugs
- Probenecid
- Bacteriostatic antibiotics
Contraindications
- Hypersensitivity to cefotaxime
- Allergy to cephalosporins
Common side effects
- Diarrhea
- Nausea
- Dizziness
- Skin rashes
Counselling Points
- Avoid driving if dizziness occurs
- Report any allergic reactions
Serious warnings
- Caution in penicillin-allergic patients
- Monitor renal function
Important Disclaimer
The Klafotaxim 500 mg.1000mg INJECTION professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
